000 | 01483 a2200469 4500 | ||
---|---|---|---|
005 | 20250511185113.0 | ||
264 | 0 | _c19930115 | |
008 | 199301s 0 0 eng d | ||
022 | _a0041-1345 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKonertz, W | |
245 | 0 | 0 |
_aIs pretransplant antiarrhythmic drug therapy a risk factor? _h[electronic resource] |
260 |
_bTransplantation proceedings _cDec 1992 |
||
300 |
_a2677-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAmiodarone _xadministration & dosage |
650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xadministration & dosage |
650 | 0 | 4 |
_aAprindine _xadministration & dosage |
650 | 0 | 4 | _aCause of Death |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aHeart Transplantation _xmortality |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMexiletine _xadministration & dosage |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPostoperative Complications _xmortality |
650 | 0 | 4 | _aPremedication |
650 | 0 | 4 |
_aPropafenone _xadministration & dosage |
650 | 0 | 4 |
_aQuinidine _xadministration & dosage |
650 | 0 | 4 |
_aSotalol _xadministration & dosage |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 |
_aTransplantation, Heterotopic _xmortality |
700 | 1 | _aWeyand, M | |
700 | 1 | _aDeiwick, M | |
700 | 1 | _aScheld, H H | |
773 | 0 |
_tTransplantation proceedings _gvol. 24 _gno. 6 _gp. 2677-8 |
|
999 |
_c1472384 _d1472384 |